A1 Refereed original research article in a scientific journal

Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT




AuthorsKauppi JT, Oksala N, Salo JA, Helin H, Karhumäki L, Kemppainen J, Sihvo EI, Räsänen JV

Publication year2012

JournalActa Oncologica

Number in series5

Volume51

Issue5

First page 636

Last page644

Number of pages9

ISSN1651-226X

eISSN1651-226X

DOIhttps://doi.org/10.3109/0284186X.2011.643822


Abstract


Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen

Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.



Read More: http://informahealthcare.com/toc/onc/51/5




Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen

Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.



Read More: http://informahealthcare.com/toc/onc/51/5




Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by [18F]FDG-PET/CT
Juha T. Kauppi, Niku Oksala, Jarmo A. Salo, Heikki Helin, Lauri Karhumäki, Jukka Kemppainen, Eero I. Sihvo, Jari V. Räsänen

Acta Oncologica May 2012, Vol. 51, No. 5: 636–644.



Read More: http://informahealthcare.com/toc/onc/51/5



Last updated on 2024-26-11 at 21:45